The global vaginal slings market accounted for USD 2.07 billion in 2023 and is expected to reach at USD 7.53 billion by 2034 with a CAGR of 12.46% during the forecast period 2024-2034. The market will increase as a result of factors such as the increasing prevalence of urinary incontinence, patient awareness and education, a focus on material innovation, growing need for efficient treatment options, and calculated alliances and collaborations.
More women are seeking solutions as a result of increased public discussion and availability of information regarding SUI and treatment choices like vaginal slings, which is driving up market demand. In an effort to increase effectiveness, prolong longevity, and lessen adverse effects, major players are in the process of investigating and creating novel materials for slings. For instance, in May 2023, Caldera Medical of PlantTec Medical announced the release of 4DRYFIELD, a polysaccharide-based solution designed to efficiently halt bleeding and avoid tissue adhesions after surgery, including vaginal sling procedures.
By product, the transobturator slings segment accounted for the highest revenue-grossing segment in the global vaginal slings market in 2023 owing to the increasing preference for minimally invasive procedures and their lower risk of complications. For instance, Boston Scientific Corporation announced in November 2023 that it will acquire Baylis Medical Company Inc., a pioneer in the creation and marketing of cutting-edge medical products. Additionally, the mini-slings segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for less invasive procedures with shorter recovery times.
By type, the midurethral sling segment accounted for the highest revenue-grossing segment in the global vaginal slings market in 2023 owing to the widespread adoption and proven efficacy in treating stress urinary incontinence. For instance, Burjeel Medical City opened an advanced gynecological institute in May 2023 to offer women of all ages complex healthcare solutions. Additionally, the traditional vaginal slings segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness and proven long-term effectiveness in treating severe cases of urinary incontinence.
By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global vaginal slings market in 2023 owing to the availability of advanced medical facilities and a higher volume of surgical procedures. For instance, in January 2024, Coloplast declared that it will purchase InVance Medical, Inc., a privately held urology-focused medical device company. Additionally, the ambulatory surgical centers (ASCs) segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing preference for cost-effective and convenient outpatient procedures.
North American region is anticipated to have the highest revenue share during the forecast period owing to the advanced healthcare infrastructure and high prevalence of urinary incontinence. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare investments and rising awareness about urinary incontinence treatments. For instance, Medtronic announced in November 2023 that the RELIEF study would begin, assessing the efficacy of the InterStim Micro system for patients experiencing fecal incontinence.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
More women are seeking solutions as a result of increased public discussion and availability of information regarding SUI and treatment choices like vaginal slings, which is driving up market demand. In an effort to increase effectiveness, prolong longevity, and lessen adverse effects, major players are in the process of investigating and creating novel materials for slings. For instance, in May 2023, Caldera Medical of PlantTec Medical announced the release of 4DRYFIELD, a polysaccharide-based solution designed to efficiently halt bleeding and avoid tissue adhesions after surgery, including vaginal sling procedures.
By product, the transobturator slings segment accounted for the highest revenue-grossing segment in the global vaginal slings market in 2023 owing to the increasing preference for minimally invasive procedures and their lower risk of complications. For instance, Boston Scientific Corporation announced in November 2023 that it will acquire Baylis Medical Company Inc., a pioneer in the creation and marketing of cutting-edge medical products. Additionally, the mini-slings segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for less invasive procedures with shorter recovery times.
By type, the midurethral sling segment accounted for the highest revenue-grossing segment in the global vaginal slings market in 2023 owing to the widespread adoption and proven efficacy in treating stress urinary incontinence. For instance, Burjeel Medical City opened an advanced gynecological institute in May 2023 to offer women of all ages complex healthcare solutions. Additionally, the traditional vaginal slings segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness and proven long-term effectiveness in treating severe cases of urinary incontinence.
By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global vaginal slings market in 2023 owing to the availability of advanced medical facilities and a higher volume of surgical procedures. For instance, in January 2024, Coloplast declared that it will purchase InVance Medical, Inc., a privately held urology-focused medical device company. Additionally, the ambulatory surgical centers (ASCs) segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing preference for cost-effective and convenient outpatient procedures.
North American region is anticipated to have the highest revenue share during the forecast period owing to the advanced healthcare infrastructure and high prevalence of urinary incontinence. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare investments and rising awareness about urinary incontinence treatments. For instance, Medtronic announced in November 2023 that the RELIEF study would begin, assessing the efficacy of the InterStim Micro system for patients experiencing fecal incontinence.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Type, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement
Segmentation: Vaginal Slings Market Report 2023 - 2034
Vaginal Slings Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Tension-Free Vaginal Tape Slings
- Transobturator Slings
- Mini-Slings
Vaginal Slings Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Midurethral Sling
- Traditional Sling
Vaginal Slings Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
Vaginal Slings Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Vaginal Slings Market: Product Estimates & Trend Analysis
8. Vaginal Slings Market: Type Estimates & Trend Analysis
9. Vaginal Slings Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Vaginal Slings Market
12. Europe Global Vaginal Slings Market
13. Asia Pacific Global Vaginal Slings Market
14. Latin America Global Vaginal Slings Market
15. MEA Global Vaginal Slings Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- Ethicon Inc.
- Coloplast Group
- C. R. Bard Inc.
- Caldera Medical Inc.
- American Medical Systems Holdings Inc.
- Promedon Group
- Betatech Medical
- A.M.I. GmbH
- Cook Medical
- Medtronic plc
- Sofradim Production
- Cousin Biotech
- Prosurg Inc.
- ACell Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 2.07 Billion |
| Forecasted Market Value ( USD | $ 7.53 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
